Resume

Endocrinology, Diabetes and Metabolism

Medical School- University Of Bombay, Mumbai, India

Residency in Internal Medicine: New York Medical College- Lincoln Program, Member of the NYC Health and Hospitals Corporation
3 year training Program in Internal Medicine

Chief Medical Resident – Lincoln Medical Center, NY (affiliated with Cornell University)

Fellowship - Clinical fellow in Endocrinology, Diabetes & Metabolism, Louisiana State University Health Sciences Center, Shreveport, LA

Private Solo Practice: Sugar Land TX
Dates: October 2009- Present

Staff Endocrinologist, Sadler Clinic, Conroe, TX
Dates: Jan 2007- Feb 2009

Assistant Professor of Medicine, Louisiana State University Health Sciences Center Staff Endocrinologist, Overton Brooks VA Medical Center/LSUHSC Shreveport, LA
Dates: June 2001 – November 2006

• In addition to performing my duties as an Endocrinologist, I was also involved in teaching Endocrinology Fellows, Residents and Medical students.

Procedural skills:

• Interpretation of Dual Energy X-ray absorptiometry (DXA or bone density): Certified by the International Society for Clinical Densitometry
• US guided FNA of thyroid nodules-Certified by the American Association of Clinical endocrinologists

Board Certified in Endocrinology, Diabetes & Metabolism: November 2000
Internal Medicine: Certified in 2000

• The Endocrine Society
• Texas Medical Association
• Fort Bend Medical Society
• Louisiana State Medical Board

• First position in Medical School Class – II year MBBS (Univ. of Bombay) 1989 – 1990 (Distinctions in Microbiology, Pharmacology, & Forensic Medicine)
• Awarded Best Resident in Award for the year 1996–1997 at Lincoln Medical Center
• Young Investigator Award: International Society for Clinical Densitometry; Annual Meeting, New Orleans, 2005

• Lababidi H., Basir R, *Subramanian V., Shapiro L., McGarry T. Glucose Intolerance among patients with asthma treated with high dose of inhaled corticosteroids. Chest: 112(3) Suppl.112S-113S
• Yaturu S., *Subramanian V. A case report of pituitary metastasis with a review of the literature: Federal Practitioner October 2004

• B.Kanna MD, J John MD, *V Subramanian MD, R Angampally MD, N Kanna MD, A Soni MD, S Kasubhai MD. Enhanced QT dispersion in Cardiac Sarcoidosis ACP-ASIM convention 1999: Oral presentation (One among the final eight for oral presentation at the National ACP Convention Resident research competition in 1999; also presented as poster in the New York Regional ACP-ASIM Chapter Conference in 1998)
• Yaturu S., * Subramanian V., Fowler M. Differentiated thyroid carcinoma in an autonomous nodule. Presented at the 81st Annual Endocrine Society Annual Meeting: San Diego-1999
• *Subramanian V., Skowsky R., Reinke F., Marr A. Multiple metastatic skin lesions from follicular thyroid carcinoma: Response to 13-cis Retinoic acid therapy. Presented at the 81st Annual Endocrine Society Meeting: San Diego-1999
• *Subramanian V., Thomas A., Skowsky R. Evaluation of serum markers of bone turnover and osteopenic risk factors in type 2 diabetics with and without peripheral neuropathy. Presented at the 59th scientific sessions of the American Diabetes Association-1999
• *Subramanian V., Yaturu S. Symptomatic ascites in a patient with hypothyroidism of recent onset. Presented at the 84th Annual Endocrine Society Meeting: San Francisco-2002
• *Subramanian V., Yaturu S., Khurana V. Predictors of bone mineral disease in patients with inflammatory bowel disease. Presented at the 85th Annual Endocrine Society Meeting: Philadelphia-2003
• *Subramanian V., Atray N., Kimball-Ravari L. Bone mineral density in elderly veterans with early renal failure. Presented at the 86th Annual Endocrine Society Meeting: New Orleans-2004
• *Subramanian V., Yaturu S. Bone mineral density trends in patients with inflammatory bowel disease: Presented at the Annual ISCD Meeting- 2005
• Intensive Review of Internal Medicine: Conducted by LSUHSC Presented the section on ‘Lipid Disorders: 2003-2006
• Rainer L, Kimball-Ravari L, *Subramanian V. Silent bilateral pheochromocytomas in a patient with Neurofibromatosis Type 1. Presented at the 88th Annual Endocrine Society Meeting: Boston- 2006